Akèy › Skleroderm Difize › North Carolina › Charlotte
Etid klinik pou Skleroderm Difize nan Charlotte, NC
3 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Charlotte (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Atrium Health Rheumatology-Southpark, Charlotte
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Ap rekriteFaz 1/2
- Nkarta Investigational Site, Charlotte
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Charlotte, Charlotte
- Artiva Investigational Site Charlotte, Charlotte
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Chicago, IL7 etid
- Ann Arbor, MI7 etid
- Durham, NC6 etid
- Los Angeles, CA6 etid
- Baltimore, MD5 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Pittsburgh, PA4 etid
- Kansas City, KS4 etid
- New Orleans, LA4 etid
- Philadelphia, PA4 etid
Lòt etid nan Charlotte
- Kansè (tout kalite)27 etid
- Kansè nan tete22 etid
- Myelom Miltip21 etid
- Kansè Poumon ki pa ti selil19 etid
- Leksemi mieloïd egi16 etid
- Obèsite16 etid
- Sipwa15 etid
- Kansè kolorektal13 etid
- Kansè ovè12 etid
- Kansè Metastatik11 etid
- Ensifizyans kadyak11 etid
- Karsinòm selil skuamèz tèt ak kou10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.